NHI vs OHI

For growth investors, Omega Healthcare Investors, Inc.

(OHI) is the stronger pick with 14. 0% revenue growth year-over-year, versus 12. 9% for National Health Investors, Inc. (NHI). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 23. 8x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate National Health Investors, Inc. (NHI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Omega Healthcare Investors, Inc.

(OHI) is the cheapest at 23. 8x versus National Health Investors, Inc. at 24. 2x. On forward P/E, National Health Investors, Inc. is actually cheaper at 21. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Omega Healthcare Investors, Inc.

(OHI) delivered a total return of +66. 3%, compared to +30. 0% for National Health Investors, Inc. (NHI). Over 10 years, the gap is even starker: OHI returned +114. 3% versus NHI's +59. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.

(OHI) is the lower-risk stock at -0. 13β versus National Health Investors, Inc. 's -0. 08β — meaning NHI is approximately -34% more volatile than OHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 78% for Omega Healthcare Investors, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Omega Healthcare Investors, Inc.

(OHI) is pulling ahead at 14. 0% versus 12. 9% for National Health Investors, Inc. (NHI). On earnings-per-share growth, the picture is similar: Omega Healthcare Investors, Inc. grew EPS 25. 2% year-over-year, compared to -3. 5% for National Health Investors, Inc.. Over a 3-year CAGR, OHI leads at 10. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Omega Healthcare Investors, Inc.

(OHI) is the more profitable company, earning 49. 3% net margin versus 37. 6% for National Health Investors, Inc. — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 51. 5% for NHI. At the gross margin level — before operating expenses — OHI leads at 44. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, National Health Investors, Inc.

(NHI) trades at 21. 6x forward P/E versus 23. 4x for Omega Healthcare Investors, Inc. — 1. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 16. 8% to $85. 40.

All stocks in this comparison pay dividends.

Omega Healthcare Investors, Inc. (OHI) offers the highest yield at 5. 4%, versus 4. 9% for National Health Investors, Inc. (NHI).

For long-horizon retirement investors, Omega Healthcare Investors, Inc.

(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +114. 3% 10Y return). Both have compounded well over 10 years (OHI: +114. 3%, NHI: +59. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.